Cancer stem cell pipeline flounders

With clinical failures mounting and companies disinvesting, researchers are revising the cancer stem cell model.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Clinical implications of the cancer stem cell hypothesis.
Authors

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Garber, K. Cancer stem cell pipeline flounders. Nat Rev Drug Discov 17, 771–773 (2018). https://doi.org/10.1038/nrd.2018.157

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing